Putting Healthcare IoT in the Home
As technologies advance, helping providers stay connected to patients through remote monitoring using the Internet of Things (IoT) is becoming more realistic. In this PharmaVOICE article, however, Rebecca Kush, Ph.D., chief scientific officer at Elligo, discusses some of the risks related to insurance and advises that IoT must prove its value before being implemented as a solution for healthcare needs.
The Uptick in AI Use Will Bring Pharma Into the Future Faster
In this PharmaVOICE article, industry experts weigh in on the potential impact of artificial intelligence (AI) in 2020. Rebecca Kush, Ph.D., chief scientific officer at Elligo, gives her perspective, which includes advice to ensure the quality and variety of the underlying data that powers it. She also shares her opinion on where AI would be most valuable: on larger studies, safety or post-marketing studies, and feasibility studies based on real-world data.